HIGHLIGHTS
- who: VEGF and colleagues from the Erasmus University Medical Center, Stanford University, United States have published the article: Circulating vascular endothelial growth factor and cancer risk: A bidirectional mendelian randomization, in the Journal: (JOURNAL)
- what: The authors performed a two-sample bidirectional MR using publicly available genome-wide association study (GWAS) summary statistics to explore the causal relationship between VEGF and the risk of multiple cancers, including breast cancer, ovarian cancer, lung cancer, colorectal carcinoma, prostate cancer, esophageal cancer, kidney cancer, bladder cancer, brain malignant tumors, and malignant tumors of the liver and intrahepatic bile . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.